Skip to main content
SpringerLink
Log in

Patterns of First-Recurrence and Post-recurrence Survival in Patients with Primary Cutaneous Melanoma After Sentinel Lymph Node Biopsy

  • Melanoma
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Sentinel lymph node biopsy (SLNB) has become well accepted in management of patients with primary cutaneous melanoma. An understanding of the pattern of recurrence after SLNB is helpful in coordinating a rational plan of follow-up in these patients. We sought to determine the site and timing of initial recurrence and post-recurrence survival after SLNB.

Methods

Stage I/II melanoma patients who underwent SLNB during 1991–2004 were identified from a prospective single-institution database. Site and date of first recurrence after SLNB were recorded. Patterns of recurrence after SLNB and post-recurrence survival were analyzed.

Results

One thousand and forty-six patients underwent SLNB. The sentinel lymph node (SLN) was positive in 164 patients (16%). Median follow-up was 36 months for survivors. Median and 3-year relapse-free survival for SLN-positive patients were 41 months and 56%, and for SLN-negative patients were not reached and 87%, respectively (P < .0001). Of the SLN-positive patients, 47% experienced recurrence, compared with 14% SLN-negative patients. The pattern of recurrence stratified by SLN status was similar between the two groups (P = NS). After recurrence, the site of recurrence was the only significant prognostic factor influencing survival (P < .0001).

Conclusions

Although SLN-positive patients experience recurrence far earlier and more frequently than SLN-negative patients, the pattern of recurrence is similar. After recurrence, its site is the primary determinant of survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.
FIG. 3.
FIG. 4.

Similar content being viewed by others

References

  1. Jemal A, Murray T, Ward E, et al. Cancer Statistics, 2006. CA Cancer J Clin 2006;56:106–30

    Article  PubMed  Google Scholar 

  2. Stadelmann W, Rapaport D, Soong S, et al. Prognostic clinical and pathologic features. In: Balch CHA, Sober A, Soong S, ed. Cutaneous Melanoma. St. Louis, MO: Quality Medical, 1998:11–35

    Google Scholar 

  3. Clary BM, Brady MS, Lewis JJ, Coit DG. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 2001;233:250–8

    Article  PubMed  CAS  Google Scholar 

  4. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253–60

    PubMed  CAS  Google Scholar 

  5. Gadd MA, Coit DG. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg 1992;127:1412–6

    PubMed  CAS  Google Scholar 

  6. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–9

    PubMed  CAS  Google Scholar 

  7. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976–83

    PubMed  CAS  Google Scholar 

  8. Gadd MA, Cosimi AB, Yu J, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 1999;134:381–7

    Article  PubMed  CAS  Google Scholar 

  9. Essner R, Conforti A, Kelley MC, et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 1999;6:442–9

    Article  PubMed  CAS  Google Scholar 

  10. McCarthy W, Shaw H, Thompson J, et al. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study. Surg Gynecol Obstet 1988;166:497–502

    PubMed  CAS  Google Scholar 

  11. Wagner JD, Gordon MS, Chuang TY, et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 2000;89:453–62

    Article  PubMed  CAS  Google Scholar 

  12. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol 2001;8:192–7

    Article  PubMed  CAS  Google Scholar 

  13. Fincher TR, McCarty TM, Fisher TL, et al. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma. Am J Surg 2003;186:675–81

    Article  PubMed  Google Scholar 

  14. Chao C, Wong SL, Ross MI, et al. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 2002;184:520–5

    Article  PubMed  Google Scholar 

  15. Zogakis TG, Essner R, Wang H, et al. Melanoma recurrence patterns after negative sentinel lymphadenectomy. Arch Surg 2005;140:865–72

    Article  PubMed  Google Scholar 

  16. Jansen L, Nieweg OE, Peterse Jl, et al. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 2000;87:484–9

    Article  PubMed  CAS  Google Scholar 

  17. Statius Muller MG, van Leeuwen PA, van Diest PJ, et al. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients. World J Surg 2002;26:1405–11

    Article  PubMed  Google Scholar 

  18. Wagner JD, Ranieri J, Evdokimow DZ, et al. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Plast Reconstr Surg 2003;112:486–97

    Article  PubMed  Google Scholar 

  19. Balch CM, Soong S, Smith T, et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol 2001;8:101–108

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York, 10021, USA

    Kimberly M. Dalal MD, Ami Patel BA, Mary S. Brady MD, David P. Jaques MD & Daniel G. Coit MD

Authors
  1. Kimberly M. Dalal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ami Patel BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mary S. Brady MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David P. Jaques MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel G. Coit MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel G. Coit MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dalal, K.M., Patel, A., Brady, M.S. et al. Patterns of First-Recurrence and Post-recurrence Survival in Patients with Primary Cutaneous Melanoma After Sentinel Lymph Node Biopsy. Ann Surg Oncol 14, 1934–1942 (2007). https://doi.org/10.1245/s10434-007-9357-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9357-0

Keywords

Search

Navigation